Van Voorhees, Abby S.

2021

Guidelines for Management of Psoriasis Screening for Comorbidities. JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION. 13:168-174.

Full Text via DOI: 10.1097/JDN.0000000000000618

2021

Proportions of biologic discontinuation among psoriasis patients with metabolic comorbidities. JOURNAL OF INVESTIGATIVE DERMATOLOGY. S49-S49.

2021

Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry. DERMATOLOGIC THERAPY.

Full Text via DOI: 10.1111/dth.14808 PMID: 33491259

2020

Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-to-Severe Psoriasis in the US Corrona Psoriasis Registry.. JOURNAL OF DERMATOLOGICAL TREATMENT.

Full Text via DOI: 10.1080/09546634.2020.1720586 PMID: 32027197

2020

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study.. Journal of the American Academy of Dermatology.

Full Text via DOI: 10.1016/j.jaad.2020.01.072 PMID: 32032692

2020

The National Psoriasis Foundation Psoriasis Treatment Targets in Real World Patients: Prevalence and Association with Patient Reported Outcomes in the Corrona Psoriasis Registry.. Journal of the European Academy of Dermatology and Venereology : JEADV.

Full Text via DOI: 10.1111/jdv.16274 PMID: 32027420

2020

What will keep women practicing dermatology?. International journal of women's dermatology. 5-6.

Full Text via DOI: 10.1016/j.ijwd.2019.08.002 PMID: 32025553

2019

Cutaneous inflammation in the DIAMOND (TM) mouse model of non-alcoholic fatty liver disease. JOURNAL OF INVESTIGATIVE DERMATOLOGY. S84-S84.

2019

The vascular inflammation in psoriasis (VIP) trial: A secondary analysis of patient reported outcomes for patients treated with adalimumab, phototherapy, or placebo. JOURNAL OF INVESTIGATIVE DERMATOLOGY. S93-S93.

2019

A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 102-110.

Full Text via DOI: 10.1016/j.jaad.2019.03.017 PMID: 30885757

2019

Achievement of the National Psoriasis Foundation Treatment Targets With Ixekizumab: Pooled Analyses From Four Clinical Studies.. Journal of the American Academy of Dermatology.

Full Text via DOI: 10.1016/j.jaad.2019.09.030 PMID: 31562945

2019

An update on generalized pustular psoriasis. EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 907-919.

Full Text via DOI: 10.1080/1744666X.2019.1648209 PMID: 31486687

2019

Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry.. The Journal of dermatological treatment. 1-8.

Full Text via DOI: 10.1080/09546634.2019.1656797 PMID: 31581919

2019

Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 81:923-930.

Full Text via DOI: 10.1016/j.jaad.2019.05.080 PMID: 31163241

2019

Peripheral Retinal Vascular Leakage in Moderate to Severe Psoriasis: A Pilot Study.. Journal of the American Academy of Dermatology.

Full Text via DOI: 10.1016/j.jaad.2019.05.067 PMID: 31150713

2019

Severe scurvy in an adult male without clear risk factors for nutritional deficiency.. JAAD case reports. 309-311.

Full Text via DOI: 10.1016/j.jdcr.2019.01.031 PMID: 30989097

2019

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. ARTHRITIS & RHEUMATOLOGY. 71:5-32.

Full Text via DOI: 10.1002/art.40726 PMID: 30499246

2019

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. ARTHRITIS CARE & RESEARCH. 71:2-29.

Full Text via DOI: 10.1002/acr.23789 PMID: 30499259

2018

Characterization of nonresponders to anti-TNFs in moderate-to-severe psoriasis patients in routine clinical practices in the US. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB69-AB69.

2018

Patient profile of nonresponders to ustekinumab in moderate-to-severe psoriasis patients enrolled in the Corrona Psoriasis Registry. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB216-AB216.

2018

Psoriasis patients achieving National Psoriasis Foundation Treat-to-Target goals and associated quality of life improvement in the Corrona Psoriasis Registry cohort. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB234-AB234.

2018

Symptom relapse following apremilast discontinuation is related to longer disease duration at treatment initiation in patients with moderate-to-severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB277-AB277.

2018

Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation A Systematic Review. JAMA DERMATOLOGY. 934-950.

Full Text via DOI: 10.1001/jamadermatol.2018.1412 PMID: 29926091

2018

Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers A Randomized Placebo-Controlled Trial. CIRCULATION-CARDIOVASCULAR IMAGING. 11.

Full Text via DOI: 10.1161/CIRCIMAGING.117.007394 PMID: 29776990

2018

Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 383-394.

Full Text via DOI: 10.1016/j.jaad.2017.06.043 PMID: 29332708

2018

A COMPREHENSIVE SURVEY ASSESSING THE FAMILY PLANNING NEEDS OF WOMEN WITH PSORIASIS. ACTA DERMATO-VENEREOLOGICA. 56-57.

2018

Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. JOURNAL OF DERMATOLOGICAL TREATMENT. 29:329-333.

Full Text via DOI: 10.1080/09546634.2017.1373737 PMID: 28884635

2017

Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. JOURNAL OF DRUGS IN DERMATOLOGY. 16:760-766.

2017

Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA DERMATOLOGY. 698-704.

Full Text via DOI: 10.1001/jamadermatol.2017.0499 PMID: 28514463

2017

Psoriasis and comorbid diseases Epidemiology. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 377-390.

Full Text via DOI: 10.1016/j.jaad.2016.07.064 PMID: 28212759

2017

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 76:290-298.

Full Text via DOI: 10.1016/j.jaad.2016.10.017 PMID: 27908543

2017

Diversity in Dermatology Residency Programs.. The journal of investigative dermatology. Symposium proceedings. S46-S49.

Full Text via DOI: 10.1016/j.jisp.2017.07.001 PMID: 28941493

2017

Psoriasis and comorbid diseases Implications for management. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 393-403.

Full Text via DOI: 10.1016/j.jaad.2016.07.065 PMID: 28212760

2017

Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation. JOURNAL OF DRUGS IN DERMATOLOGY. 16:760-766.

PMID: 28809991

2016

From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 798-U254.

Full Text via DOI: 10.1016/j.jaad.2016.06.014 PMID: 27461230

2016

Factors associated with biopsy site identification, postponement of surgery, and patient confidence in a dermatologic surgery practice. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 74:1185-1193.

Full Text via DOI: 10.1016/j.jaad.2015.12.019 PMID: 26853178

2016

Research objectives and design of the Corrona Psoriasis Registry: A large prospective cohort of psoriasis patients in the United States. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. AB268-AB268.

2016

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 17:87-97.

Full Text via DOI: 10.1007/s40257-015-0169-x PMID: 26718712

2016

Severe Small-Vessel Vasculitis Temporally Associated With Administration of Ustekinumab.. JOURNAL OF DRUGS IN DERMATOLOGY. 359-62.

PMID: 26954323

2015

Annual screening for tuberculosis in patients on TNF-alfa antagonists. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. E123-E123.

Full Text via DOI: 10.1016/j.jaad.2015.04.071 PMID: 26282816

2015

Combining Biologic TherapiesWith Other Systemic Treatments in Psoriasis Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation. JAMA DERMATOLOGY. 432-438.

Full Text via DOI: 10.1001/jamadermatol.2014.3456 PMID: 25517130

2015

Phototherapy in dermatology: A call for action. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1078-1080.

Full Text via DOI: 10.1016/j.jaad.2015.03.017 PMID: 25981004

2015

Reply to: "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors''. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 744-744.

Full Text via DOI: 10.1016/j.jaad.2014.08.056 PMID: 25773422

2015

Treatment of Nail Psoriasis Best Practice Recommendations From the Medical Board of the National Psoriasis Foundation. JAMA DERMATOLOGY. 151:87-94.

Full Text via DOI: 10.1001/jamadermatol.2014.2983 PMID: 25471223

2015

Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 868-870.

Full Text via DOI: 10.1016/j.jaad.2015.07.001 PMID: 26475541

2014

Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 71:1167-1175.

Full Text via DOI: 10.1016/j.jaad.2014.08.003 PMID: 25260564

2014

From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 70:178-186.

Full Text via DOI: 10.1016/j.jaad.2013.08.049 PMID: 24220724

2014

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 168-177.

Full Text via DOI: 10.1016/j.jaad.2013.09.020 PMID: 24184141

2014

Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 71:623-632.

Full Text via DOI: 10.1016/j.jaad.2014.04.063 PMID: 24894455

2014

Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. BRITISH JOURNAL OF DERMATOLOGY. 170:672-680.

Full Text via DOI: 10.1111/bjd.12745 PMID: 24266717

2014

Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 71:633-641.

Full Text via DOI: 10.1016/j.jaad.2014.05.001 PMID: 24928705

2014

Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 39:19-24.

Full Text via DOI: 10.1111/ced.12250 PMID: 24341476

2014

Research gaps in psoriasis: Opportunities for future studies. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 70:146-167.

Full Text via DOI: 10.1016/j.jaad.2013.08.042 PMID: 24126079

2013

Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity. JOURNAL OF DERMATOLOGICAL TREATMENT. 24:255-260.

Full Text via DOI: 10.3109/09546634.2012.759639 PMID: 23249143

2013

From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1003-1013.

Full Text via DOI: 10.1016/j.jaad.2013.06.046 PMID: 24075223

2013

Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 68:64-72.

Full Text via DOI: 10.1016/j.jaad.2012.06.035 PMID: 22846688

2013

TSLP Elicits IL-33-Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation. SCIENCE TRANSLATIONAL MEDICINE. 5.

Full Text via DOI: 10.1126/scitranslmed.3005374 PMID: 23363980

2013

Using Hawthorne Effects to Improve Adherence in Clinical Practice: Lessons From Clinical Trials Reply. JAMA DERMATOLOGY. 491-491.

Full Text via DOI: 10.1001/jamadermatol.2013.2846 PMID: 23715064

2013

Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 68:262-269.

Full Text via DOI: 10.1016/j.jaad.2012.07.007 PMID: 22910105

2012

Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting. ARCHIVES OF DERMATOLOGY. 148:487-494.

Full Text via DOI: 10.1001/archdermatol.2012.370 PMID: 22508874

2012

Consensus Guidelines for the Management of Plaque Psoriasis. ARCHIVES OF DERMATOLOGY. 148:95-102.

Full Text via DOI: 10.1001/archdermatol.2011.1410 PMID: 22250239

2012

Dermatologist Preferences for Treatments to Compare in Future Randomized Controlled Comparative Effectiveness Trials for Moderate to Severe Psoriasis. ARCHIVES OF DERMATOLOGY. 539-541.

Full Text via DOI: 10.1001/archdermatol.2011.1399 PMID: 22508884

2012

Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 66:376-386.

Full Text via DOI: 10.1016/j.jaad.2011.03.012 PMID: 21856040

2012

Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 459-477.

Full Text via DOI: 10.1016/j.jaad.2011.07.039 PMID: 22018758

2012

The impact of psoriasis on 10-year Framingham risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 796-798.

Full Text via DOI: 10.1016/j.jaad.2012.05.016 PMID: 22739354

2012

Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 279-288.

Full Text via DOI: 10.1016/j.jaad.2011.01.032 PMID: 22609220

2011

Guidelines of care for the management of psoriasis and psoriatic arthritis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 65:137-174.

Full Text via DOI: 10.1016/j.jaad.2010.11.055 PMID: 21306785

2011

In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?". JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 788-790.

Full Text via DOI: 10.1016/j.jaad.2010.10.033 PMID: 21414501

2011

Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 65:537-545.

Full Text via DOI: 10.1016/j.jaad.2010.05.014 PMID: 21496950

2011

Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG-PET/CT). ARCHIVES OF DERMATOLOGY. 147:1031-1039.

Full Text via DOI: 10.1001/archdermatol.2011.119 PMID: 21576552

2011

Treatment of Refractory Tumor Necrosis Factor Inhibitor-Induced Palmoplantar Pustulosis: A Report of 2 Cases. ARCHIVES OF DERMATOLOGY. 1228-1230.

Full Text via DOI: 10.1001/archdermatol.2011.275 PMID: 22006150

2010

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 114-135.

Full Text via DOI: 10.1016/j.jaad.2009.08.026 PMID: 19811850

2010

Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1058-1069.

Full Text via DOI: 10.1016/j.jaad.2009.09.053 PMID: 20692722

2010

Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 163:334-339.

Full Text via DOI: 10.1111/j.1365-2133.2010.09899.x PMID: 20545678

2010

Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 291-299.

Full Text via DOI: 10.1016/j.jaad.2009.03.047 PMID: 19646777

2010

Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 655-662.

Full Text via DOI: 10.1016/j.jaad.2009.05.048 PMID: 19665821

2007

National Psoriasis Foundation clinical consensus on disease severity. ARCHIVES OF DERMATOLOGY. 143:239-242.

Researchers@EVMS

Van Voorhees, Abby S.
Close

Contact Info

Publications

selected publications

Contact

full name

visualizations

research areas